MDPI and ACS Style
Cebatoriene, D.; Vilkeviciute, A.; Gedvilaite-Vaicechauskiene, G.; Duseikaite, M.; Bruzaite, A.; Kriauciuniene, L.; Zaliuniene, D.; Liutkeviciene, R.
The Impact of ARMS2 (rs10490924), VEGFA (rs3024997), TNFRSF1B (rs1061622), TNFRSF1A (rs4149576), and IL1B1 (rs1143623) Polymorphisms and Serum Levels on Age-Related Macular Degeneration Development and Therapeutic Responses. Int. J. Mol. Sci. 2024, 25, 9750.
https://doi.org/10.3390/ijms25179750
AMA Style
Cebatoriene D, Vilkeviciute A, Gedvilaite-Vaicechauskiene G, Duseikaite M, Bruzaite A, Kriauciuniene L, Zaliuniene D, Liutkeviciene R.
The Impact of ARMS2 (rs10490924), VEGFA (rs3024997), TNFRSF1B (rs1061622), TNFRSF1A (rs4149576), and IL1B1 (rs1143623) Polymorphisms and Serum Levels on Age-Related Macular Degeneration Development and Therapeutic Responses. International Journal of Molecular Sciences. 2024; 25(17):9750.
https://doi.org/10.3390/ijms25179750
Chicago/Turabian Style
Cebatoriene, Dzastina, Alvita Vilkeviciute, Greta Gedvilaite-Vaicechauskiene, Monika Duseikaite, Akvile Bruzaite, Loresa Kriauciuniene, Dalia Zaliuniene, and Rasa Liutkeviciene.
2024. "The Impact of ARMS2 (rs10490924), VEGFA (rs3024997), TNFRSF1B (rs1061622), TNFRSF1A (rs4149576), and IL1B1 (rs1143623) Polymorphisms and Serum Levels on Age-Related Macular Degeneration Development and Therapeutic Responses" International Journal of Molecular Sciences 25, no. 17: 9750.
https://doi.org/10.3390/ijms25179750